Screening compound: BKOHESAPWYBROF-DEOSSOPVSA-N

Screening compound: BKOHESAPWYBROF-DEOSSOPVSA-N
Screening compound: BKOHESAPWYBROF-DEOSSOPVSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
BKOHESAPWYBROF-DEOSSOPVSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L610-0099

Molecular Formula

C27H31N3O3 (C27 H31 N3 O3)

Compound Name

N~1~-(cyclohexylmethyl)-4-{[5,11-dioxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepin-10(5H)-yl]methyl}benzamide

IUPAC name

N-(cyclohexylmethyl)-4-({28-dioxo-39-diazatricyclo[8.4.0.0^{37}]tetradeca-1(14)1012-trien-9-yl}methyl)benzamide

SMILES

O=C(c1ccc(CN(c(cccc2)c2C(N2C3CCC2)=O)C3=O)cc1)NCC1CCCCC1

InChI

InChI=1S/C27H31N3O3/c31-25(28-17-19-7-2-1-3-8-19)21-14-12-20(13-15-21)18-30-23-10-5-4-9-22(23)26(32)29-16-6-11-24(29)27(30)33/h4-5,9-10,12-15,19,24H,1-3,6-8,11,16-18H2,(H,28,31)/t24-/m0/s1

InChI Key

BKOHESAPWYBROF-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD27465817

BKOHESAPWYBROF-DEOSSOPVSA-N in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Hsp90-Targeted Library (11355 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Epigenetics Focused Set (26518 compounds)

MDM2-p53 interaction inhibitors Library (21687 compounds)

Peptidomimetic Library (37031 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with BKOHESAPWYBROF-DEOSSOPVSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound BKOHESAPWYBROF-DEOSSOPVSA-N?
Check Price and Availability of BKOHESAPWYBROF-DEOSSOPVSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of BKOHESAPWYBROF-DEOSSOPVSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for BKOHESAPWYBROF-DEOSSOPVSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for BKOHESAPWYBROF-DEOSSOPVSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of BKOHESAPWYBROF-DEOSSOPVSA-N available by request